Skip to content

Recovery Inspired Support Engagement (RISE) Pilot

Recovery Inspired Support Engagement (RISE) Pilot

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07519759
Acronym
(RISE)
Enrollment
18
Registered
2026-04-09
Start date
2026-09-14
Completion date
2028-02-28
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers, Chosen Family, Family Members, Friends, Romantic Partners, Substance Use Disorders, Support Persons

Keywords

Support Persons, Friends, Substance Use Disorders, Alcohol, Substance Use (Drugs, Alcohol), Social Support, Recovery, Invitation to Change, ITC, Romantic Partners, Chosen Family, Family Members, Caregivers

Brief summary

The goal of this clinical trial is to learn if a 1-on-1 support program is easy to complete and acceptable for people supporting loved ones who have recently received treatment for substance use. The main questions it aims to answer are: How many people complete the program? How satisfied are people with the program? Participants will: Complete weekly telehealth sessions for 12 weeks Complete surveys/interviews at the beginning, in the middle (\ week 6), at the end of the program (\ week 12), and 12-weeks after the end of the program Complete a focus group or interview

Detailed description

The program aims to improve support person well-being, social recovery capital, and their loved one's substance use outcomes. Information from support persons and loved ones with a substance use disorder will be collected for program feedback and hypothesis generating purposes. Target enrollment for the clinical trial is 15 pairs of support persons and their loved one. We will plan to recruit 18 pairs of participants in case some people may not complete the study (\ 15%). Total planned enrollment of support persons (n=18) and their loved ones (n=18) is N=36.

Interventions

BEHAVIORALITC

ITC is a behavioral intervention delivered via telehealth. The coaching session topics include skills to help with understanding, awareness, and action. The intervention is designed for support persons of individuals living with a substance use disorder.

Sponsors

Mclean Hospital
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Inclusion Criteria for Support Persons: * Ages 18+. * Having a loved one who participated in an inpatient or residential substance use disorder program in the past 30 days, as reported by loved one, support person, clinician, or chart review. * Interest in supporting the loved one's recovery from substance use. * At least 4 days per month virtual or in-person contact per month with the loved one. * Access to a computer with internet or mobile phone with video conferencing capabilities. * Ability to provide written informed consent. * Speak and read English. * Inclusion Criteria for Loved Ones: * Ages 18+. * Participated in an inpatient or residential substance use disorder program in the past 30 days, as reported by self, support person, clinician, or chart review. * At least 4 days per month virtual or in-person contact per month with the support person. * Access to a computer with internet or mobile phone with video conferencing capabilities. * Ability to provide written informed consent. * Speak and read English.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Program CompletionFrom enrollment to the end of the program (12 weeks).Proportion of participants completing 12-session program

Secondary

MeasureTime frameDescription
Mean Session SatisfactionFrom enrollment to the end of the program (12 weeks).Participants will report weekly satisfaction (helpfulness) ratings following each session on the Session Survey. Ratings will range from 1 (poor) to 5 (excellent).

Countries

United States

Contacts

CONTACTJulie M McCarthy, PhD
jmccarthy@mclean.harvard.edu16178553521
CONTACTRoger D Weiss, PhD
rweiss@mclean.harvard.edu617-855-2242

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026